186 related articles for article (PubMed ID: 16842062)
21. The burden of rare diseases.
Ferreira CR
Am J Med Genet A; 2019 Jun; 179(6):885-892. PubMed ID: 30883013
[TBL] [Abstract][Full Text] [Related]
22. A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC).
Cutillo CM; Austin CP; Groft SC
Adv Exp Med Biol; 2017; 1031():349-369. PubMed ID: 29214582
[TBL] [Abstract][Full Text] [Related]
23. A comparison of country and metropolitan general practice.
Britt H; Miles DA; Bridges-Webb C; Neary S; Charles J; Traynor V
Med J Aust; 1993 Nov; 159(S2):S9-64. PubMed ID: 8232056
[TBL] [Abstract][Full Text] [Related]
24. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
Liu BC; He L; He G; He Y
J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of Rare Lung Diseases: The Challenges and Opportunities to Improve Research and Knowledge.
McCarthy C; Lara Gallego B; Trapnell BC; McCormack FX
Adv Exp Med Biol; 2017; 1031():419-442. PubMed ID: 29214586
[TBL] [Abstract][Full Text] [Related]
26. [RARE DISEASES DTC: DIAGNOSIS, TREATMENT AND CARE].
Mendlovic J; Barash H; Yardeni H; Banet-Levi Y; Yonath H; Raas-Rothschild A
Harefuah; 2016 Apr; 155(4):241-4, 253. PubMed ID: 27323543
[TBL] [Abstract][Full Text] [Related]
27. Orphan drugs: the regulatory environment.
Franco P
Drug Discov Today; 2013 Feb; 18(3-4):163-72. PubMed ID: 22981668
[TBL] [Abstract][Full Text] [Related]
28. Incentivizing Orphan Product Development: United States Food and Drug Administration Orphan Incentive Programs.
Le TT
Adv Exp Med Biol; 2017; 1031():183-196. PubMed ID: 29214572
[TBL] [Abstract][Full Text] [Related]
29. [Rare diseases are not orphan any longer].
Cordier JF
Rev Prat; 2012 Jan; 62(1):3. PubMed ID: 22335057
[No Abstract] [Full Text] [Related]
30. Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen.
Giannuzzi V; Conte R; Landi A; Ottomano SA; Bonifazi D; Baiardi P; Bonifazi F; Ceci A
Orphanet J Rare Dis; 2017 Apr; 12(1):64. PubMed ID: 28372595
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiologic challenges in rare diseases].
Rückinger S; Boneberger A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 May; 51(5):483-90. PubMed ID: 18696139
[TBL] [Abstract][Full Text] [Related]
32. [Rare diseases, definitions and epidemiology].
Donnart A; Viollet V; Roinet-Tournay M
Soins Pediatr Pueric; 2013; (274):14-6. PubMed ID: 24228328
[TBL] [Abstract][Full Text] [Related]
33. Intractable and rare diseases research in Asia.
Song P; Gao J; Inagaki Y; Kokudo N; Tang W
Biosci Trends; 2012 Apr; 6(2):48-51. PubMed ID: 22621985
[TBL] [Abstract][Full Text] [Related]
34. Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.
Humbert M; Wagner TO
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232421
[No Abstract] [Full Text] [Related]
35. Legal assessment of current situation on orphan patients in Lithuania.
Spokiene I
Medicina (Kaunas); 2008; 44(8):571-6. PubMed ID: 18791333
[TBL] [Abstract][Full Text] [Related]
36. Supporting patients with a rare disease.
Ypinazar V
Aust Fam Physician; 2015 Sep; 44(9):644-5. PubMed ID: 26488042
[No Abstract] [Full Text] [Related]
37. Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data.
Groft SC; de la Paz MP
Adv Exp Med Biol; 2010; 686():3-14. PubMed ID: 20824436
[TBL] [Abstract][Full Text] [Related]
38. Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.
Richter T; Nestler-Parr S; Babela R; Khan ZM; Tesoro T; Molsen E; Hughes DA;
Value Health; 2015 Sep; 18(6):906-14. PubMed ID: 26409619
[TBL] [Abstract][Full Text] [Related]
39. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
Dolfus H; Lévy N
Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
[No Abstract] [Full Text] [Related]
40. Progress, challenges and global approaches to rare diseases.
Groft SC; Posada M; Taruscio D
Acta Paediatr; 2021 Oct; 110(10):2711-2716. PubMed ID: 34105798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
